The Company continues to strengthen its intellectual property portfolio for IGALMI™ (dexmedetomidine) sublingual film. The Company currently has 12 listed patents for IGALMI in the FDA’s Approved Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback